Shree Pandya

Summary

Affiliation: University of Rochester
Country: USA

Publications

  1. pmc Validation of the individualised neuromuscular quality of life for the USA with comparison of the impact of muscle disease on those living in USA versus UK
    Reza Sadjadi
    Department of Neurology, King s College Hospital, Denmark Hill, London SE5 9RS, UK
    Health Qual Life Outcomes 9:114. 2011
  2. ncbi request reprint Facioscapulohumeral dystrophy
    Shree Pandya
    School of Medicine and Dentistry, University of Rochester, Rochester, NY 14627, USA
    Phys Ther 88:105-13. 2008
  3. ncbi request reprint Severity, type, and distribution of myotonic discharges are different in type 1 and type 2 myotonic dystrophy
    Eric L Logigian
    Neuromuscular Division, Department of Neurology, Box 673, 601 Elmwood Avenue, University of Rochester Medical Center, Rochester, New York 14642, USA
    Muscle Nerve 35:479-85. 2007
  4. ncbi request reprint Computerized hand grip myometry reliably measures myotonia and muscle strength in myotonic dystrophy (DM1)
    Richard T Moxley
    Department of Neurology, University of Rochester Medical Center, Box 673, 601 Elmwood Avenue, Rochester, New York 14642, USA
    Muscle Nerve 36:320-8. 2007
  5. doi request reprint Delayed diagnosis in duchenne muscular dystrophy: data from the Muscular Dystrophy Surveillance, Tracking, and Research Network (MD STARnet)
    Emma Ciafaloni
    Department of Neurology, University of Rochester, Rochester, NY, USA
    J Pediatr 155:380-5. 2009
  6. doi request reprint Change in natural history of Duchenne muscular dystrophy with long-term corticosteroid treatment: implications for management
    Richard T Moxley
    Department of Neurology, University of Rochester, Rochester, NY 14642, USA
    J Child Neurol 25:1116-29. 2010
  7. ncbi request reprint Limb-girdle muscular dystrophy in the United States
    Steven A Moore
    University of Iowa, Iowa City, 52242, USA
    J Neuropathol Exp Neurol 65:995-1003. 2006

Collaborators

  • Eric L Logigian
  • Rabi Tawil
  • Timothy M Miller
  • Katherine D Mathews
  • Charlotte M Druschel
  • A Pestronk
  • Jerry R Mendell
  • Richard T Moxley
  • Emma Ciafaloni
  • Reza Sadjadi
  • Deborah J Fox
  • John T Kissel
  • Steven A Moore
  • Jessica Walburn
  • Victoria L Brooks
  • Michael R Rose
  • Kelly A Vincent
  • Alison J Carr
  • Carlayne E Jackson
  • Kim Campbell
  • Christina P Westfield
  • Lisa A Miller
  • Christopher Cunniff
  • Soman Puzhankara
  • Dennis J Matthews
  • Paul A Romitti
  • Nuran Dilek
  • Chris L Annis
  • Charles A Thornton
  • Allen W Wiegner
  • Cheryl A Barbieri
  • William B Martens
  • Hansell H Stedman
  • Christopher J Shilling
  • Matthew P Wicklund
  • Federica Piccolo
  • Robert C Griggs
  • Daniel Darvish
  • Daniel E Michele
  • Catherine Stolle
  • Rita Barresi
  • Charlotte A Brown
  • Nick King
  • Kevin P Campbell
  • Wendy King
  • Gerald M Fenichel
  • Julaine Florence
  • Steven Westra
  • Aaron Stence
  • Cheryl Wall
  • Carmen Serrano
  • Thomas L Winder

Detail Information

Publications7

  1. pmc Validation of the individualised neuromuscular quality of life for the USA with comparison of the impact of muscle disease on those living in USA versus UK
    Reza Sadjadi
    Department of Neurology, King s College Hospital, Denmark Hill, London SE5 9RS, UK
    Health Qual Life Outcomes 9:114. 2011
    ..It may be important to understand any cultural differences in how patients rate their QoL when applying QoL measures in multi-national clinical trials...
  2. ncbi request reprint Facioscapulohumeral dystrophy
    Shree Pandya
    School of Medicine and Dentistry, University of Rochester, Rochester, NY 14627, USA
    Phys Ther 88:105-13. 2008
    ..The purposes of this article are to increase awareness of FSHD among clinicians; to provide an update regarding the genetics, clinical features, natural history, and current management of FSHD; and to discuss opportunities for research...
  3. ncbi request reprint Severity, type, and distribution of myotonic discharges are different in type 1 and type 2 myotonic dystrophy
    Eric L Logigian
    Neuromuscular Division, Department of Neurology, Box 673, 601 Elmwood Avenue, University of Rochester Medical Center, Rochester, New York 14642, USA
    Muscle Nerve 35:479-85. 2007
    ..It tends to be waxing-waning in DM1 but waning in DM2, thus making electrodiagnosis of DM2 more challenging. Its severity correlates with muscle weakness and the presence of waxing-waning discharges in DM1 but not DM2...
  4. ncbi request reprint Computerized hand grip myometry reliably measures myotonia and muscle strength in myotonic dystrophy (DM1)
    Richard T Moxley
    Department of Neurology, University of Rochester Medical Center, Box 673, 601 Elmwood Avenue, Rochester, New York 14642, USA
    Muscle Nerve 36:320-8. 2007
    ..We conclude that computerized handgrip myometry provides a sensitive, reliable measure of myotonia and strength in DM1 and offers a method to assess natural history and response to treatment...
  5. doi request reprint Delayed diagnosis in duchenne muscular dystrophy: data from the Muscular Dystrophy Surveillance, Tracking, and Research Network (MD STARnet)
    Emma Ciafaloni
    Department of Neurology, University of Rochester, Rochester, NY, USA
    J Pediatr 155:380-5. 2009
    ..To identify key factors for the delay in diagnosis of Duchenne muscular dystrophy (DMD) without known family history...
  6. doi request reprint Change in natural history of Duchenne muscular dystrophy with long-term corticosteroid treatment: implications for management
    Richard T Moxley
    Department of Neurology, University of Rochester, Rochester, NY 14642, USA
    J Child Neurol 25:1116-29. 2010
    ..Educational, vocational, and other social counseling is now a vital part of management for Duchenne muscular dystrophy...
  7. ncbi request reprint Limb-girdle muscular dystrophy in the United States
    Steven A Moore
    University of Iowa, Iowa City, 52242, USA
    J Neuropathol Exp Neurol 65:995-1003. 2006
    ..The most common LGMDs in the United States are calpainopathies, dysferlinopathies, sarcoglycanopathies, and dystroglycanopathies...